British Journal of Urology

OCT 11, 2026 · JOURNAL ARTICLE

Prognostic biomarkers in non‐muscle‐invasive bladder cancer: biological basis and evidence

British Journal of Urology

Objectives To review prognostic and treatment‐response biomarkers for non‐muscle‐invasive bladder cancer (NMIBC), with particular attention to biological function, specimen type, a

OCT 8, 2026 · JOURNAL ARTICLE

Fracture risk and initiation of bone‐specific drug therapy following radical cystectomy with urinary diversion

British Journal of Urology

Objectives To assess the risk of fractures among patients with bladder cancer who underwent radical cystectomy (RC) with urinary diversion (UD), compared with matched referents fro

OCT 5, 2026 · JOURNAL ARTICLE

Testosterone breakthrough and outcomes during intensified therapy in metastatic hormone‐sensitive prostate cancer: the ARASENS and LATITUDE trials

British Journal of Urology

Objectives To assess whether treatment‐period serum testosterone breakthrough >35 ng/dL is associated with clinical outcomes during intensified therapy for metastatic hormone‐sensi

AUG 14, 2026 · JOURNAL ARTICLE

Evaluation of triplet therapy combined with robot‐assisted cytoreductive prostatectomy for high‐volume metastatic prostate cancer: a multicentre randomised controlled trial protocol

British Journal of Urology

This is a protocol for a planned RCT that has not yet reported results; it describes the design and rationale but presents no efficacy or safety data, making it a prospective study announcement rather than evidence of effectiveness.

AUG 12, 2026 · JOURNAL ARTICLE

Long‐term oncological outcomes from a prospective cohort of patients with localised prostate cancer

British Journal of Urology

Population-based prospective cohort with long-term follow-up (10 years) and hard clinical outcomes (prostate cancer-specific mortality, overall survival) across multiple treatment modalities, though observational design and residual confounding limit causal inference.